3 completed. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
Follow Practice Guidelines as Topic: new trials by email Literature Review of Practice Guidelines as Topic trials Research Report on Practice Guidelines as Topic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Website Smoking Cessation Intervention for the Promotion of Smoking Cessation in Low-Income Veterans Smoking Cessation Intervention (New website), Smoking Cessation Intervention (Standard of care website), Health Education - Cigarette Smoking-Related Carcinoma | Phase 1 | Completed | Fred Hutchinson Cancer Center | 53 | 2021-02-03 | 2023-04-07 |
| Leflunomide for the Treatment of Severe COVID-19 in Patients With a Concurrent Malignancy Best Practice, Leflunomide, Placebo Administration - Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm | Phase 1 / Phase 2 | Completed | City of Hope Medical Center | 2 | 2021-01-07 | 2024-07-03 |
| Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization Best Practice, Ibrutinib - Aplastic Anemia, Hematopoietic and Lymphoid Cell Neoplasm | Phase 1 | Completed | Jennifer Woyach | 10 | 2020-10-23 | 2023-12-26 |
Hematologic Neoplasms (2) · Anemia, Aplastic (1) · Monoclonal Gammopathy of Undetermined Significance (1) · Myelodysplastic Syndromes (1)
City of Hope Medical Center (1) · Fred Hutchinson Cancer Center (1) · Jennifer Woyach (1)
United States (3)
Jaimee Heffner (1) · Jennifer A Woyach, MD (1) · Sanjeet S Dadwal (1)
P30CA033572 (1), R21CA236980 (1)